ConAgra Brands Q1 2026 Earnings EPS Misses Estimates Amid Cautious Market Reaction Sagimet Biosciences Inc Q1 2026 Earnings Narrowed Loss Beats Expectations as Clinical Pipeline Advances LNKB Q4 2025 Earnings Earnings Miss Highlights Persistent Headwinds Day One Biopharmaceuticals DAWN Q4 2025 Earnings EPS Miss Reflects RD Spend Amid PreRevenue Status NovaBridge Biosciences NBP Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Rises 508 IMRX Q1 2026 Earnings Narrower Loss Exceeds Expectations as Pipeline Progress Continues